← Insider buys
PCRX

Pacira BioSciences, Inc. · Healthcare

Chief Medical Officer Jonathan Slonin sold $80K of Pacira BioSciences, Inc.

Sold$80,117
$28.25Price
2,836Shares
−3%Stake

What PCRX did after the filing

Filed Jul 3, copier in the same day
The stock from Wed, Jul 3 close, $21.66
−38.4%
S&P 500, same days
+0.3%

Measured over 30 trading days, to the Aug 15 close.

Traded Tue, Jul 2. Filed Wed, Jul 3, 2:52 PM ET, during the session. Returns use the Jul 3 close and the Aug 15 close. Not investment advice.